It has been clinically proven that a history of pulmonary tuberculosis is closely associated with an increased risk of lung cancer,35 and blocking the PD‐1/PDL1 signaling pathway may benefit patients with Mycobacterium tuberculosis or other chronic infections, or even prevent their cancer development.36 The gene discussed is CD274; the disease is lung cancer.